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The Recruitment of monocytes to the pre-ovulatory ovary 
Alex Whitaker 
Ovulation is a recurring biological process that involves inflammatory reactions that 
degrade and restructure tissue.  It requires the chemotaxis of leukocytes to the ovary to 
help regulate and promote these events.  Hormonal signals and chemokines that are 
released during the peri-ovulatory period initiate the release of specific leukocyte 
populations, possibly from the spleen, that infiltrate the ovary and facilitate the release of 
oocytes from ovarian follicles.  These studies utilized a super-ovulation protocol to 
initiate ovulation in immature balb/c and cd1 mice.  Ovaries were collected at several 
times post human chorionic gonadotropin (hCG) injection and analyzed by multi-color 
flow cytometry.  Oviducts were collected from mice 20 hours after hCG administration 
and cumulous oocyte complexes were collected, counted and averaged to determine 
ovulation rate.  Immunohistochemistry was used to determine the location of specific cell 
types in the ovary.  We identified a specific population of monocytes, deemed ly6𝑐ℎ𝑖𝑔ℎ 
monocytes, which infiltrate the ovary at a specific time.  Immediately before ovulation 
occurs, ly6𝑐ℎ𝑖𝑔ℎ monocytes are found in increased numbers in the ovaries, possibly to 
promote inflammation and follicular rupture.  After ovulation, the numbers of these 
monocytes decreases rapidly, likely because once they enter the tissues they differentiate 
into either M1 macrophages, to further promote inflammation, or M2 macrophages to 
stimulate corpus luteum development.  Studies have shown that animals deficient of these 
subsets of monocytes and macrophages have reduced rates of ovulation.  Several other 
leukocyte populations were identified infiltrating the ovary, suggesting multiple 
leukocyte subsets are involved in ovulation.  In this regard, in the ovary, the 
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ly6𝑐ℎ𝑖𝑔ℎmonocytes may function as a source of M1 and M2 macrophages that initiate the 
inflammatory process and facilitate the rest of the reproductive process. 
Keywords: flow cytometry, neutrophil, Ly6𝑐ℎ𝑖𝑔ℎ monocyte, macrophage, ovulation 
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Chapter 1 
Introduction 
 Ovulation 
 In many women, ovulation is a naturally occurring, monthly inflammatory 
process that results in the release of an oocyte for possible fertilization.  Ovulation is 
brought about by many physiological changes, such as fluctuations in hormonal levels 
and cell signaling1.  These changes cause different types and numbers of white blood 
cells to migrate to the ovaries to ensure ovulation occurs successfully2.  Specifically, the 
types of white blood cells found in follicular fluid include granulocytes, lymphocytes, 
monocytes and macrophages2.  It has also been reported that macrophages, neutrophils, 
eosinophils and mast cells are recruited to the theca layer of follicles3,4.  These cells are 
recruited to very specific areas in the ovaries, namely directly to the follicle at the 
boundary between the theca and granulosa cells.  This infiltration, at precise points 
during the ovulatory process, leads to a weakening of the follicular wall and follicular 
rupture.  Subsequently, the leukocytes are also critical for corpus luteum formation and 
luteolysis1,5,6.  In regards to ovulation, many of these inflammatory leukocytes can be 
found near mature follicles, releasing products such as matrix metalloproteinases and 
proteolytic enzymes that will help weaken the follicular wall, allowing oocyte release, 
and helping to reorganize tissue6,7.   
Without these regular alterations in physiology, the recruitment of white blood 
cells is hindered, and ovulation either has a reduced success rate or does not occur, 
resulting in reduced fertility and reproductive diseases such as polycystic ovarian 
syndrome (PCOS)8.   A genetic defect in any key component in the formation or 
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recruitment of leukocytes can result in reduced ovulatory success.  For example, mice 
that have decreased levels of colony-stimulating factor-1, and therefore decreased 
macrophage numbers, do not ovulate normally3,9.  Mice that have malfunctioning 
macrophages also have abnormal ovulation rates3,9.  When these specific white blood cell 
populations are absent, the success of ovulation can be reduced by as much as 50 
percent7,9.  Specific populations of white blood cells are necessary for ovulation to occur, 
as they release cytokines and enzymes that help promote the inflammation at the ovarian 
follicles so that they will rupture and release the oocyte, or egg cell1.  After follicular 
rupture, other white blood cells promote tissue repair and clean up the process of 
ovulation can restart and the corpus luteum can form and be maintained6.  The corpus 
luteum is important in maintaining pregnancy via progesterone secretion.  These 
processes are able to occur because white blood cells, including monocytes and 
macrophages, produce cytokines, which can recruit more white blood cells to this natural 
site of inflammation as well as promote further inflammation by accumulating in large 
quantities7.  One of the key roles of the ovaries is steroidogenesis; the recruitment of 
leukocytes to the ovary may also facilitate steroidogenesis in ovarian cells such as 
granulosa-lutein cells2. 
 Leukocytes have been implicated as a major factor in ovulation for many reasons.  
One reason to support their role is that a hindered or abnormal ovulation process appears 
when leukocyte numbers are decreased or non-functioning.  Many genetic defects and 
immune diseases can result in incorrectly functioning white blood cells, or can cause 
reduced numbers or their complete absence.  In these instances, fertility issues often arise.  
For example, in splenectomized mice and in osteopetrotic mice that cannot produce 
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macrophage colony-stimulating factor-1 (MCF-1), there are reduced numbers of 
leukocytes and macrophages, respectively, and in both cases, pregnancy rates and litter 
sizes are reduced3,6,7,9.  Similarly, a mutation in the microftalmia locus causes 
macrophages to malfunction, resulting in lowered ovulation success3.  In individuals that 
have normal leukocyte numbers and activity, their leukocyte activity or recruitment can 
be blocked by various mechanisms.  For instance, by using antibodies against 
neutrophils, or by blocking the chemokine interleukin-8, neutrophils can be stopped from 
reaching the ovary or working properly, causing ovulation to become aberrant3.  
Indomethacin, which is a non-steroidal anti-inflammatory (NSAID) drug, has also been 
shown to inhibit ovulation rates by hindering prostaglandin pathways and causing 
abnormal follicle rupture3.  Furthermore, upon being provided with adequate numbers of 
normally functioning leukocytes, ovulatory rates seem to be restored.  In instances where 
leukocytes are abnormal through a genetic defect, the patient treated with a bone marrow 
transplantation demonstrated recovered ovulation rates3,9.  Lastly, leukocytes have been 
implicated in playing a role in ovulation merely by their presence as well as their 
products.  Macrophages, monocytes, mast cells, eosinophils, and neutrophils have all 
been found in ovarian tissue3.  Many products of leukocytes have been observed in 
ovaries during and after ovulation, including growth factors, cytokines, and chemokines, 
which help recruit leukocytes to the site and promote the inflammatory process of 
ovulation2,10.  In fact, chemokine gene transcription has been demonstrated to be at its 
highest in the ovary before ovulation takes place, indicating leukocytes are needed for 
ovulation and likely for corpus luteum formation as well6. 
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 The specific populations of white blood cells entering the ovaries, how they 
function and how they are involved in causing ovulation has yet to be fully elucidated.  
The exact source of these cells has also not been confirmed.  However, it is clear that 
they are integral to ovarian function including ovulation, corpus luteum formation, and 
corpus luteum degradation.  Once the specific populations of leukocytes involved in 
successful ovulation together with the signals recruiting them to the ovary can be 
identified, we will be able to better treat patients suffering from ovarian reproductive 
problems. 
Estrogen and Ovulation 
 Estrogen is one of the most influential hormones in the female body.  Estrogen 
occurs in three forms; estrone, estradiol, and estriol.  This hormone helps regulate a 
multitude of physiological processes, especially those relating to female reproduction.  
Estradiol is the most potent of the three estrogen forms and predominates throughout the 
fertile years of a woman’s life.  Estrone predominates after menopause in women, while 
estriol is the major form found during pregnancy.  Estrogen has an anti-inflammatory 
effect and can regulate the expression of many cell adhesion molecules on the 
endothelium11.  Specifically, estrogen decreases expression of adhesion molecules on the 
vascular endothelium, causing it to regulate the number of leukocytes that are able to 
migrate (extravasate) into the tissue11.   Estrogen is also capable of suppressing key 
transcription factors, such as NF-κβ.  The NF-κβ pathway is involved in regulating a 
multitude of immune cell genes and cytokines, as well as lowering chemokine production 
of GRO3 (CXCL3), ultimately reducing recruitment of polymorphonuclear cells, such as 
neutrophils11.  The anti-inflammatory nature of estrogen is highlighted by the 
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exacerbation of inflammatory diseases seen in women once they become post-
menopausal and circulating levels of estrogen are decreased11.  The drop in estrogen 
levels before ovulation and the subsequent ovarian influx of leukocytes is likely a critical 
signal allowing for leukocyte recruitment. 
 There are several hormones involved in the process of ovulation, the levels of 
which fluctuate throughout the cycle.  Estrogen, particularly estradiol, is one of the most 
predominant hormones influencing ovulation.  During the follicular phase of ovulation, 
estrogen levels continuously rise until ovulation occurs.  After ovulation, estrogen levels 
drop sharply, and the levels of another important hormone, progesterone, rise greatly.  
After ovulation occurs, the ruptured follicle forms a corpus luteum, which secretes high 
levels of progesterone.  If pregnancy occurs, then progesterone levels will remain high, 
but levels will drop if no implantation occurs, allowing corpus luteum regression and 
menstruation to occur.  Progesterone plays a role in a variety of reproductive events, and 
makes the uterus a hospitable environment for implantation and zygote development by 
making the tissue extremely vascular.  There are also two gonadotropic hormones 
involved in the process of ovulation.  These include follicle stimulating hormone (FSH), 
which promotes the growth of immature ovarian follicles, and luteinizing hormone (LH), 
which triggers ovulation and promotes the growth of the corpus luteum6.  The levels of 
both FSH and LH remain low until immediately before ovulation. At this point both 
hormone concentrations rapidly rise, with a slight increase in FSH levels and a much 
larger spike in LH levels. FSH is necessary to trigger folliculogenesis while LH plays a 
more significant role in causing ovulation to occur and corpus luteum develop. 
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Figure 1. Hormone fluctuation in menstrual cycle.  
There are many hormones involved in the process of ovulation, which include the ovarian 
hormones estradiol and progesterone, and the gonadotropins, follicle stimulating hormone and 
luteinizing hormone. Day 0 through approximately 15 correlates to the follicular phase, when the 
follicle grows and endometrium thickens, and day 15 through 28 corresponds to the secretory 
phase, at which corpus luteum formation occurs. Ovulation occurs in between these two phases, 
which is stimulated by the LH surge12. Source: Therapy Insight: preserving fertility in 
cyclophosphamide-treated patients with rheumatic disease. Dooley, M. A. & Nair, R. Nature 
clinical practice. Rheumatology 4, 250-257, doi:10.1038/ncprheum0770 (2008). 
Follicle Development 
In the ovary, there are many follicles that contain an oocyte which will go through 
many changes involving growth and maturation, ovulation, corpus luteum development 
and regression6.  Follicles first assemble, then develop and mature, and finally ovulate; 
each process is a part of folliculogenesis13.  First, primordial follicles form and are 
completely developed at birth, and constitute the reserve a female will have throughout 
her life until they are all used, resulting in menopause14.  At rest, these primordial 
follicles are small and do not develop further; however when the primordial follicles 
leave the reserve they will continue to mature and develop14.  Primordial follicles will 
grow in size and become structurally more complex as they develop into mature follicles.  
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There are varying sizes of follicles that can be grouped into three distinct classes based 
on their size and complexity.  Primary follicles are the smallest and consist of a growing 
oocyte surrounded by a layer of cuboidal granulosa cells, which begin to express FSH 
receptors14.  The zona pelucida begins to form at this stage, which surrounds the oocyte.  
These continue to develop and grow and can then be classified as secondary follicles, 
which consists of two to ten layers of granulosa cells surrounding a fully grown oocyte 
inside the zona pelucida, and a basal lamina surrounding the granulosa cells.  Theca cells 
also develop outside of the basal lamina at this stage of folliculogenesis, which is where 
blood vessels begin to form.  These blood vessels will bring the hormones necessary for 
further development to the follicle.  When the follicle begins to show a cavity, or antrum, 
at one side of the oocyte in the granulosa cells, it is termed a tertiary follicle.  When a 
follicle is completely mature, there is follicular fluid in the antrum.  The last step of 
folliculogenesis entails ovulation, at which point the follicle ruptures and releases the 
oocyte for fertilization13. 
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Figure 2. An ovarian Graafian follicle.  
A mature ovarian follicle with an oocyte in the center. Granulosa cells surround the oocyte. A 
basement membrane separates granulosa cells from theca cells. (From Erickson GF: The ovary: 
Basic principles and concepts. Source: Felig P, Baxter JD, Broadus AE, Froman LA, (eds): 
Endocrinology and Metabolism. 3rd ed. New York: McGraw-Hill, 1987. 
Gonadotropins and hormones play a large role in directing the development of 
follicles to become preovulatory.  FSH is the primary hormone stimulating follicles to 
start growing15.  Follicle growth begins when FSH reaches the ovary, which is detected 
by receptors on granulosa cells.  FSH causes granulosa cells to rapidly divide and  to 
express the enzyme aromatase, that cleaves testosterone into estradiol15.  LH is the 
second gonadotropin that plays an important role in ovulation.  Theca cells, on the outer 
layer of the follicle, respond to LH and will begin to produce testosterone15.  Testosterone 
diffuses through the basement membrane to the granulosa cells on the inner layer of the 
follicle, convert it to estradiol through the enzyme aromatase15.  This is all initiated by the 
rush of LH reaching the ovary in the middle of the ovulation cycle15.  LH also determines 
which follicle is the most mature or dominant because it is detected to a greater degree by 
the follicle with more LH receptors and fewer FSH receptors15.  It temporarily stops all 
other follicles from continuing to mature.  The mid-cycle surge of LH also promotes 
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granulosa cells to become luteinized after ovulation6,15.  The effects of both important 
gonadotropins can be mimicked by using pregnant mare serum gonadotropin (PMSG) 
and human chorionic gonadotropin (hCG), which mimic FSH and LH respectively.  
These two compounds are readily available to use in laboratory settings for reproductive 
research. 
Mature follicles that are not selected for ovulation will undergo atresia, meaning 
most cells in the atretic follicle will go through apoptosis.  The selected follicle will 
continue to develop through ovulation, which occurs after the follicle ruptures from a 
variety of proteases degrade the basal membrane2.  In mice, multiple follicles will go 
through this process instead of the typical single follicle ovulating in humans1.  This 
breakdown releases the oocyte, along with cumulous cells which are differentiated from 
granulosa cells.  These cumulous cells are mucous-like and will protect the oocyte and 
help carry it down the oviduct, fallopian tube in humans.  The leftover follicular cells will 
develop into the corpus luteum, which will produce progesterone6,16,17.  If the oocyte does 
not get fertilized and no pregnancy occurs, then the corpus luteum will degrade, stop 
synthesizing progesterone, and the uterine lining will degrade and return to normal15.  If 
pregnancy does occur, the corpus luteum is responsible for continued progesterone 
production, which keeps the uterine wall thick and full of blood vessels for zygote 
development16.  
The ovarian tissue, specifically the theca and granulosa cells, are believed to be 
derived from the immune system.  Both cell types, especially theca cells, are capable of 
secreting interleukin-8, which is a major recruitment factor for leukocytes10.  Monocytes 
are able to induce this secretion in ovarian tissue10.  Corpus luteum formation and 
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degradation, like ovulation, is also highly associated with immune cell changes16.  
Granulosa-lutein cells have been implicated as a source of chemokine release, which is 
necessary for attracting leukocytes to help with corpus luteum remodeling2.  One study 
was able to show an increase in interleukin-8 production in cultures of granulosa lutein 
cells and leukocytes compared to cultures of only granulosa lutein cells1,2.  The 
interaction between ovarian cells and leukocytes seems to be effective at optimizing 
production of chemokines and hormones1.  The regulation of chemokine production in 
ovarian cells is thought to involve stimuli such as hCG, tumor necrosis factor-alpha, and 
interleukin-12.  The changes in chemokine expression are also cyclic, indicating 
leukocyte infiltration is necessary at precise times in the estrus cycle1.  Neutrophils are an 
important inflammatory cell that have been found in ovarian tissue during ovulation, 
specifically around the thecal layer of follicles2.  Neutrophils are abundant during corpus 
luteal formation, while monocytes and macrophages seem to dominate during corpus 
luteal degradation1,16. 
Reproductive Diseases 
Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine 
disorder among women, affecting an estimated one in five women of reproductive age in 
the United States18,19.  The disease often presents with enlarged ovaries that have cysts on 
them, limiting function and estrogen production, ultimately resulting in hormonal 
imbalance.  The hormonal imbalance causes the manifestation of symptoms such as 
excessive acne, balding or hair thinning, amenorrhea or irregular menstruation, facial hair 
growth, insulin resistance and obesity20.  PCOS can also lead to hypertension, diabetes, 
and a metabolic syndrome19.  This disease is often associated with reproductive 
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challenges and infertility.  One chemokine, monocyte chemoattractant protein-1, has been 
identified in follicular fluid and serum in women with PCOS in increased levels 
compared to healthy women19.  Increased serum levels of this particular chemokine may 
be promoting the insulin resistance and obesity that is seen in PCOS women19.  This 
suggests that specific amounts of chemokines, cytokines and leukocytes are required in 
the reproductive tissue of healthy women ONLY at precise times, with quantities outside 
that threshold resulting in reproductive irregularities and diseases.  
Endometriosis is another major reproductive disorder, characterized by the 
abnormal ectopic growth of endometrial tissue outside the uterine cavity21,22.  This 
disease has been associated with decreased function of T cells and natural killer cells, and 
increased activation and infiltration of macrophages21,22. 
Spleen 
 The spleen is a secondary lymphoid organ which functions to filter blood, 
removing old red blood cells and monitoring for and removing abnormal or pathogenic 
particles via its resident population of immune cells23,24.  Monocytes and macrophages, 
among other leukocytes, can be found in the spleen24.  The spleen has recently been 
identified as a reservoir for leukocytes, acting as an immediate source of white blood 
cells when tissue becomes damaged or inflamed23.  This is in contrast to the bone 
marrow, which is a much slower acting source of leukocytes for damaged tissue.  In 
particular, ly6𝑐ℎ𝑖𝑔ℎ and ly6𝑐𝑙𝑜𝑤 monocytes have been found in the red pulp of the spleen, 
and the ly6𝑐ℎ𝑖𝑔ℎ  monocytes in particular have been proven to be specifically recruited 
from the spleen to sites of tissue injury23.  One study found that, after inducing ischemia 
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of the myocardium, there was a decrease in ly6c monocyte numbers in the spleen, an 
increase in their numbers in the blood, and no change in bone marrow numbers, 
indicating the monocytes left the spleen and entered circulation to reach the site of 
injury23.  However, this same study showed that neutrophil numbers in the spleen did not 
change23.  
The immune system plays an important role in the reproductive system, as an 
abnormal immune system is associated with various fertility complications, such as 
preeclampsia, intrauterine growth restriction, and recurring abortions24.  There has been 
some indication that the spleen is the source of leukocyte donation for the ovary, as 
splenectomized mice have reduced ovulation rates compared to both mice with intact 
spleens or mice that have been reconstituted with splenocytes8.  Furthermore, women 
who have had splenectomies and become pregnant endured more hardships than women 
who had a spleen, including the increased need for caesarian section and fertility 
treatment, and a higher risk for preterm delivery24.  It has also been demonstrated that an 
inverse correlation between leukocyte numbers in the spleen and in the ovary exists 
during ovulation7.  This suggests that the spleen may play a role in the reproductive 
system, and may also act as a source of leukocytes for normal, physiological 
inflammatory processes, such as ovulation.  The spleen is likely supplying leukocytes to 
reproductive tissues, such as the ovary, oviduct, and uterus, to facilitate a rapid and 
timely ovulation.  Furthermore, bone marrow transplants have been shown to be effective 
at restoring ovulation rates in rodents with defective white blood cells3.  Sources of white 
blood cells, like the spleen or bone marrow, may both be capable of restoring ovulatory 
function. 
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Figure 3. Splenic leukocyte recruitment to ovary.  
The spleen may act as a reservoir for leukocytes, releasing them in response to chemokines 
released by ovarian cells. Following ovarian infiltration, the leukocytes migrate to a mature 
follicle, and begin to release cytokines and chemokines to help break down the follicle membrane 
so that ovulation can occur. Source:  Pituitary-ovary-spleen axis in ovulation. Oakley OR, Frazer 
ML, and Ko C. (2011). Trends in endocrinology and metabolism: TEM 22, pp.345-352. 
 
Ly6𝒄𝒉𝒊𝒈𝒉 Monocyte 
 Monocytes are innate white blood cells that arise in the bone marrow and travel 
through the vasculature to inflamed or infected tissue sites, where they eventually 
differentiate into macrophages or dendritic cells25-29.  They are typically some of the first 
leukocytes to arrive at inflammatory sites4,28.  Peripheral inflammation is typically a 
primary signal causing increased production of monocytes27.  In the vasculature, 
monocytes interact with cell adhesion molecules, such as the vascular cell adhesion 
molecule (VCAM-1) and the intercellular adhesion molecule (ICAM-1), expressed by the 
endothelium which help slow the monocytes so that they can pass through the 
endothelium to reach the inflamed tissue and differentiate into macrophages30.  
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Monocytes are characterized by the expression of CD11b, CD115 in mice, CD14 and 
CD16 in humans, and lack the surface markers expressed by B, T, natural killer, and 
dendritic cells, which include B220, CD3, NK1.1, MHCII (IA), and CD90.225,27.  They 
are also distinguishable from their differentiated forms, macrophage and dendritic cells, 
by their lack of F4/80 glycoprotein and CD11c expression23.  There are two predominant 
subsets of monocytes, which are the ly6𝑐ℎ𝑖𝑔ℎ and ly6𝑐𝑙𝑜𝑤 monocyte, named by the 
variable levels of expression of ly6c (lymphocyte antigen 6c)23.  These two subsets are 
functionally distinct and express different surface markers23,28.  The ly6𝑐ℎ𝑖𝑔ℎ monocyte is 
inflammatory while ly6𝑐𝑙𝑜𝑤 monocyte is involved in the resolution of 
inflammation23,25,28,31. 
 
Figure 4. Two functionally distinct subsets of monocytes.  
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The ly6𝒄𝒉𝒊𝒈𝒉 monocyte can differentiate into an inflammatory M1-like macrophage upon tissue 
infiltration. It can also patrol the vasculature, decreasing ly6c expression to become a ly6𝒄𝒍𝒐𝒘 
monocyte. The ly6𝒄𝒍𝒐𝒘 monocyte can differentiate into an M1-like macrophage upon tissue 
infiltration, which functions primarily to resolve inflammation and repair tissue.32 Source: 
Monocytes in atherosclerosis: subsets and functions. Woollard, K. J. & Geissmann, F. Nature 
reviews. Cardiology 7, 77-86, doi:10.1038/nrcardio.2009.228 (2010). 
The ly6𝑐ℎ𝑖𝑔ℎ monocytes are short-lived cells involved in inflammatory processes 
and typically migrate to infected or inflamed tissue25,27,28,31,33.  Ly6𝑐ℎ𝑖𝑔ℎ populations are 
a transitory subset because they quickly begin to lower expression of ly6c after entering 
the circulation and tissues27,28.  These inflammatory monocytes are typically one of the 
first immune cells to arrive at a site of injury34. They are larger than their ly6𝑐𝑙𝑜𝑤 
counterpart23 and express the chemokine receptor 𝐶𝑋3CR1 in low levels, but express high 
levels of Ly6c (Gr-1) and the chemokine CCR225,26,28,31,33.  In humans, this same 
monocyte is classified as 𝐶𝑋3CR1
𝑙𝑜𝑤𝐶𝐷14ℎ𝑖𝑔ℎ for surface receptor expression31.  CCR2 
is the major chemokine receptor utilized by this monocyte to infiltrate inflamed tissues 
and cross the endothelium26,31,35.  Blocking CCR2 activity results in drastically reduced 
monocyte numbers31.  Similarly, knocking out the gene for CCR2 (CCR2−/−) in mice 
also causes drastically decreased recruitment of monocytes and macrophages to tissue36.  
Ly6𝑐ℎ𝑖𝑔ℎ monocytes also express chemokine receptors CCR7 and CCR8, and migrate 
towards chemokines such as CCL2, CCL7, and CCL831.  These chemokines were 
previously named to reflect their function as monocyte chemoattractant proteins; for 
instance, CCL2 was previously referred to as monocyte chemoattractant protein-1 (MCP-
1)5.  These ligands are produced by endothelial tissue, helping recruit leukocytes to 
specific tissues; in the pre-ovulatory ovary, CCL2 is produced by stroma cells near the 
follicle, recruiting macrophages to this specific site1.  They are also produced by 
fibroblasts, smooth muscle cells, and other monocytes, macrophages, and 
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lymphocytes19,29.  CCL2 production is often increased in response to inflammatory 
stimuli such as TNF-α, interferon-gamma (IFN-γ), and lipopolysaccharide, which is a 
product of pathogens29.  In addition, it escalates an inflammatory process by stimulating 
adhesion molecule and cytokine production35.  Another molecule present on the ly6𝑐ℎ𝑖𝑔ℎ 
monocyte is L-selectin, or CD62L, that facilitates the monocyte homing to inflamed 
tissues27.  This subset of monocytes can differentiate into ly6𝑐𝑙𝑜𝑤 monocytes simply by 
decreasing expression of ly6c or develop into an M1 macrophage, the classical pro-
inflammatory macrophage26,27,30,33.  Since it can differentiate into a ly6𝑐𝑙𝑜𝑤 monocyte, it 
can further differentiate into wound repair M2 type macrophages34.  Though most 
monocytes differentiate into macrophages upon exiting the bloodstream, this transition is 
not always immediate34.  These monocytes can also exhibit regulatory functions on other 
white blood cells, such as neutrophils, and stop them from becoming activated by 
producing prostaglandin E2 (PG𝐸2) and interleukin-10
37.  One study was able to show 
that in the presence of commensal bacteria, ly6𝑐ℎ𝑖𝑔ℎ were able to take on a regulatory 
role in addition to their inflammatory role, to limit collateral damage from other 
inflammatory leukocytes, especially neutrophils37. 
In the ovary, these monocytes would be found before ovulation occurs, as they 
promote the inflammation and swelling of the ovarian follicles.  The follicles will 
eventually rupture and release oocytes for fertilization.  They may also be involved in the 
process of corpus luteum degradation, which would be highly inflammatory.  Monocytes 
may also be playing a regulatory role on the ovarian cells, causing granulosa-lutein cells 
to secrete interleukin-8 and MCP-1, which would prompt the recruitment of more 
leukocytes6,10.  Furthermore, they may be able to regulate other inflammatory cells, like 
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neutrophils, and prevent them from releasing damaging products too early or in too high 
a concentration37. 
Ly6𝒄𝒍𝒐𝒘 Monocyte 
The ly6𝑐𝑙𝑜𝑤 monocytes are non-inflammatory; they promote wound healing, 
tissue repair and remodeling23,33.  These monocytes are also capable of promoting 
angiogenesis and fibrosis in wounds34.  The ly6𝑐𝑙𝑜𝑤 monocytes are also better at 
processing apoptotic cells than their counterpart, which helps them in repairing tissue33.  
These monocytes express the chemokine receptor 𝐶𝑋3CR1 in high levels, but express 
low levels of ly6c and the chemokine CCR225-27,31,33. This monocyte in humans can be 
characterized as having 𝐶𝑋3CR1
ℎ𝑖𝑔ℎ𝐶𝐷14𝑙𝑜𝑤𝐶𝐷16ℎ𝑖𝑔ℎ  expression31.  The ly6𝑐𝑙𝑜𝑤 
monocytes are recruited to tissues where there is an excess of 𝐶𝑋3CL1, also known as 
fractalkine, that is expressed on endothelial tissue and smooth muscle cells5,25-27,35,38.  
Fractalkine is able to cause monocyte adhesion and facilitate chemotaxis25,38.  Fractalkine 
is also specialized in that it is able to be cleaved from its membrane-bound form into a 
soluble product that can accumulate to further promote chemotaxis of monocytes35,38,39.  
This particular chemokine binds to the G-coupled protein receptor 𝐶𝑋3CR1, which is 
expressed by monocytes and macrophages38.  Fractalkine increases when responding to 
hCG, resulting in increased production of progesterone by granulosa cells1.  These 
monocytes are longer-lived cells and can become residential macrophages in tissues, 
especially those that are noninflamed25-27,31,33.  This subset of monocytes has been 
described as an intermediate between ly6𝑐ℎ𝑖𝑔ℎ monocytes and ly6𝑐𝑙𝑜𝑤 macrophages, as 
ly6𝑐ℎ𝑖𝑔ℎ monocytes gradually reduce ly6c expression27,31,34.  They can also differentiate 
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into the alternatively activated M2 macrophage, that promotes tissue repair and 
remodeling30.  
In the ovary, these monocytes would appear after ovulation has occurred, 
indicating they could repair the ruptured follicle tissue.  This monocyte may also be 
involved in corpus luteal formation, which is needed upon successful fertilization of an 
oocyte1.  Corpus luteal formation involves a tremendous amount of tissue remodeling and 
vascularization, suggesting these monocytes may play a role in the task.  
M1 Macrophage 
 Monocytes that enter tissue will eventually differentiate into macrophages, 
especially if they come into contact with M-CSF27.  Macrophages are cells that are 
involved in the innate immune system, and can help destroy pathogens, remove apoptotic 
cells, and promote angiogenesis40.  Monocyte differentiation is dependent on the tissue 
environment they enter and whether they encounter inflammatory or anti-inflammatory 
cytokines, chemokines, or other products.  Monocytes can be either classically or 
alternatively activated, causing them to turn into either a more damaging M1 macrophage 
or a wound-healing M2 macrophage, respectively.  Macrophages have been implicated in 
playing a role in ovulation, with a variety of studies finding the presence of macrophages 
in ovarian tissue during ovulatory events3.  Macrophages have also been identified as the 
most abundant type of leukocyte in the ovary40.  Macrophages can promote angiogenesis 
and are involved in maintaining the vasculature of the corpus luteum40. 
M1-like macrophages appear after monocytes encounter lipopolysaccharide, 
interferon-gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α), which are all 
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inflammatory signals30,40.  The M1 macrophages will continue to promote inflammatory 
processes and proteolysis of tissue by secreting such cytokines as IL-6 and IL-12, as well 
as TNF-α and IFN- γ 30,34,40.  They will also release CCL2, CCL7, and CCL8, which will 
recruit more ly6𝑐ℎ𝑖𝑔ℎ monocytes to the inflamed tissue30.  M1-macrophages are powerful 
effector cells; they destroy pathogens and apoptotic cells, as well as promote the 
progression of the inflammatory process40.  M1-like macrophages have been identified in 
the regressing corpus luteum, likely cleaning up dead or dying cells1,40.  Inflammatory 
products, such as TNF-α, also increase during luteolysis, helping to promote apoptosis of 
luteal cells while recruiting more leukocytes1. 
M2 Macrophage 
 The ly6𝑐𝑙𝑜𝑤 monocytes develop into the alternatively activated M2-like 
macrophages, that are responsible for cleaning up and repairing damaged tissue, as well 
as remodeling it.  These macrophages are often called wound healing macrophages. M2-
like macrophages are more likely to appear in environments filled with anti-inflammatory 
products, such as interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-13 (IL-
13)40.  They can produce a variety of anti-inflammatory mediators, such as tumor growth 
factor-beta (TGF-β)34 and vascular endothelial growth factor (VEGF), that promotes 
angiogenesis40.  These macrophages are characterized by low expression of ly6c and high 
expression of F4/80 and MHC class II, as well as the expression of CD206 (mannose 
receptor), Mer tyrosine kinase (MerTK), and FC receptors CD23 and CD6434.  M2-like 
macrophages are also anti-inflammatory and can induce apoptosis in other immune cells, 
such as neutrophils, to reduce overall inflammatory reactions 34.  They stimulate CD4+ T 
helper 2 cells and regulatory cells, which along with the M2 macrophage, are better able 
 
 
20 
 
to regulate immune processes and help tissue repair40.  M2-like macrophages have been 
found in the developing corpus luteum in high levels, suggestive of an involvement in 
promoting angiogenesis40.  These cells may also help regulate immune responses in the 
ovary during these complex processes in a homeostatic manner1. 
Neutrophils 
 Neutrophils are polymorphonuclear granulocytes and are the most abundant of 
circulating leukocytes40.  They are short lived cells that are part of the innate immune 
system, responding early to inflammatory stimuli40.  Granulocyte colony stimulating 
factor promotes the proliferation of neutrophils40.  Neutrophils produce very toxic and 
damaging products, such as reactive oxygen species (ROS), proteases, superoxides, and 
cytokines, that both clear pathogens and destroy tissue17,37.  They also contain many 
proteolytic enzymes, such as collagenases and elastases, that are used to degrade 
extracellular matrix to facilitate extravasation into tissues5,17.  These granulocytic 
leukocytes are both attracted to and activated by Interleukin-84,5.  Another potent factor 
causing neutrophil attraction is growth-regulated oncogene-α4,5.  Both of these 
chemoattractants can be categorized into the CXC subfamily of chemokines4,5.  
Neutrophils have been shown to appear in ovarian follicles before ovulation takes 
place, suggesting they play a role in the inflammatory process leading to ovulation3,4,6.  
Specifically, they have been found accumulate in the theca layers of preovulatory 
ovaries3,4.  They have also been found around follicles that rupture abnormally3.  In 
support of this idea, administering neutralizing antibodies against neutrophils reduces 
ovulation rates in rats3,40.  A similar effect occurs when antibodies are given against IL-8, 
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which inhibits neutrophils from entering tissue, resulting in decreased ovulation rate3.  
Neutrophils may be modulated in the ovulation process by ly6𝑐ℎ𝑖𝑔ℎ monocytes that 
produce PG𝐸237. PG𝐸2 is able to regulate smooth muscle cells, endothelial cells and 
white blood cells and their production of cytokines, chemokines, and expression of 
adhesion molecules41.  This regulation of activity might help to keep the neutrophils from 
weakening follicular walls until optimal conditions are met and oocytes are ready to burst 
from the follicle.  Neutrophils may also play a role after ovulation in corpus luteum 
development by promoting angiogenesis1,40.  
Chemotaxis 
 Chemotaxis is the movement of a cell from one area to another in response to a 
specific chemical gradient or cue, and is typically a major process involved in immune 
responses6,42.  This process can both attract and repel specific cells, based on the cue 
provided6.  Leukocytes are constantly monitoring the body for immune disturbances by 
circulating through the blood stream until they are attracted to a particular site in response 
to chemokines, which are soluble proteins that promote chemotaxis6.  In many instances, 
chemokines, which are small, low molecular weight cytokines with chemoattractant 
properties, are responsible for chemotaxis, as well as leukocyte activation5,10,36,43.  
Chemokines are structurally very similar and are divided into four subfamilies based on 
the location of their cysteine residues, which are C, CC, CXC, and C𝑋3C
4,5,10,21,42,43.  
Because of their comparable structures, many chemokines share similar functions, 
making them redundant.  Chemokines are typically inflammatory as they can activate 
leukocytes and effectively recruit leukocytes to sub-endothelial tissues42,44.  Chemokines 
are produced and released by endothelial cells and stromal cells, that assist leukocytes in 
 
 
22 
 
determining where they need to go, and also by leukocytes themselves, self-promoting 
the number of leukocytes recruited6.  Some important leukocytes recruited to tissue via 
chemokine gradients include monocytes, macrophages and neutrophils, which are often 
the first immune cells to appear at inflammatory sites.  Chemokines in the CC family tend 
to recruit monocytes and lymphocytes, while neutrophils respond primarily to the CXC 
subfamily5,21.  Several chemokines have been found in and around follicles in the ovary 
and have thus been implicated in ovarian function5.  Chemokine regulation in the ovary is 
complex and specific, allowing for specific leukocytes to be recruited to precise locations 
in the ovary at optimal times to cause ovulation and the following reproductive processes 
to occur efficiently5.  
 Monocyte chemoattractant proteins 1, 2, and 3 (MCP-1, MCP-2, MCP-3), also 
called CCL2, CCL8, and CCL7, respectively, are some of the primary chemokines 
responsible for the chemotaxis of monocytes36,42,45,46.  These chemokines are categorized 
into the CC subfamily (or beta family) and have approximately 70% shared homologous 
structure36,42,44,45.  CCL2 can be produced by a variety of cells, including endometrial 
stromal cells and mesothelial cells, in response to a variety of triggers, such as estrogen21.  
CCL2 is involved in follicle development, ovulation, steroidogenesis, and corpus luteum 
formation, which suggests that hormones may be acting as catalysts to increase 
production of CCL219.  They also are produced in response to inflammatory signals, such 
as cytokines29.  The monocyte chemoattractant proteins bind to G-protein coupled 
receptors (GPCRs), resulting in various signaling cascades5,36,42,45,46.  The chemokine 
receptor CCR2 is an example of one of these GPCRs on monocytes, which is expressed 
in abundance and is the predominant receptor allowing for monocyte recruitment, only 
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binding specifically to monocyte chemoattractant proteins29,36,42,44,46,47.  There are two 
isoforms of CCR2, named alpha and beta, in humans, but only one form in mice36.  
Knockout of the CCR2 gene results in greatly decreased monocyte and macrophage 
recruitment to tissue, showing just how important this receptor is for monocyte 
recruitment36.  CCL2 has been identified in the pre-ovulatory ovary, as well as indicated 
as a likely player in corpus luteum formation, as it has angiogenic abilities5.  It is also one 
of the major chemokines involved in corpus luteum degradation, and is considered an 
indicator of luteolysis5.  The presence of CCL2 in such high levels in the ovary at each of 
these reproductive stages suggests the necessity of monocyte involvement. 
 Neutrophils and other leukocytes are both drawn toward and activated by the 
chemokine interleukin-8 (IL-8)2,4-6,45.  Interleukin-8 is classified as a CXC (alpha family) 
chemokine2,4-6,10.  This chemokine has been found in both human follicular fluid and 
granulosa-lutein cells in pre-ovulatory follicles, indicating the presence of neutrophils 
during ovulation1,10.  Furthermore, IL-8 is secreted by theca cells and granulosa cells, as 
well as leukocytes, indicating there is a necessity for white blood cells in the ovary2,6,10.  
The level of IL-8 secreted increases as follicles grow, with the highest amounts produced 
by dominant follicles10.  IL-8 may also be a regulator of steroid synthesis in the ovary and 
initiate ovulatory events10.  Another likely chemoattractant for neutrophils are the 
collagen-like peptides that result from tissue degradation of the basement membrane in 
ovarian follicles3,17.  Growth regulated oncogenes (GRO) are also members of the CXC 
family; they are primarily chemotactic for neutrophils but can also be potent activators of 
them as well3-5,45.  They bind to the CXCR2 receptor, while IL-8 can bind to both the 
CXCR1 and CXCR2 receptors45.  Growth related oncogenes are more chemotactically 
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potent than interleukin-84.  The expression of GRO has been found in the pre-ovulatory 
ovary of rats3.  Both IL-8 and GRO-α have been found in high concentrations in human 
follicular fluid4.  They have also been determined to be expressed on preovulatory 
follicles5.  TNF-α, which is an inflammatory product itself, has been identified as a signal 
that causes increased production of both GRO-α and IL-8 in granulosa lutein cells4,5.  
Estrogen, which can modulate many physiological processes, has been demonstrated as 
being capable of reducing GRO3 (CXCL3), thereby reducing neutrophil recruitment11.  
Another modulator of GRO expression is hCG, which is able to increase GRO 
expression5.  It may also be that different mechanisms of recruitment are enacted to draw 
neutrophils to specific locations.  In one study where indomethacin was used to inhibit 
neutrophil infiltration into the ovary, it was shown that neutrophils were blocked from 
entering the medulla but still were able to reach the follicle, suggesting multiple 
mechanisms of recruitment3.  GRO and IL-8 are capable of promoting angiogenesis, and 
therefore have a possible role in corpus luteum development5,6.  Furthermore, these two 
chemokines have been found in the pre-ovulatory ovary, suggesting that neutrophils are a 
major class of white blood cells stimulating reproductive processes such as ovulation5. 
 There are also adhesion molecules on endothelial tissue which alter in expression 
to recruit immune cells through extravasation.  Expression of adhesion molecules on 
endothelial tissue are necessary for leukocyte recruitment; they work by slowing down 
circulating leukocytes and helping them adhere to endothelial tissue, and then by drawing 
them through the endothelium into tissues that require them.  These molecules include 
platelet-endothelial cell adhesion molecule -1 (PECAM-1, CD31), intercellular adhesion 
molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and E-selectin, all of 
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which play a role in stimulating leukocyte recruitment from circulation into tissue.  
PECAM-1, through intracellular signaling, can induce activation in other inflammatory 
genes, like ICAM-1, to promote the inflammatory process7.  ICAM-1 is able to help 
leukocytes slow down and adhere to endothelial tissue, so that PECAM-1 can be more 
effective at drawing them into tissue from circulation7.  Both PECAM-1 and ICAM-1 
have increased expression prior to ovulation, indicating leukocytes are actively recruited 
to the ovary7.   
Fractalkine, or C𝑋3𝐶𝐿1, is a chemokine that falls into the C𝑋3𝐶 family; however 
it is different from other chemokines because it is the only member in this class43.  
Fractalkine is expressed on the membrane of endothelial cells and smooth muscle cells, 
signaling leukocytes to adhere to specific tissue35,38.  This adherence helps leukocytes 
lose velocity in the bloodstream and stick to vessel walls, facilitating migration into the 
tissues.  Fractalkine expression varies depending on the environment; inflammatory 
stimuli such as LPS decrease expression, while factors such as IL-10, have the alternative 
effect of increasing expression38.  Furthermore, fractalkine is unique compared to other 
chemokines as it can also be cleaved by TNF-α-converting enzyme, which leaves behind 
soluble fractalkine39,43.  This soluble form can aggregate in large quantities and act as a 
chemoattractant for leukocytes as well as smooth muscle cells43.  Any cell expressing 
C𝑋3𝐶𝑅1, the receptor for C𝑋3𝐶𝐿1, is capable of adhering to or migrating towards this 
ligand38.  In addition to these functions, fractalkine can also induce proliferation of 
smooth muscle cells by acting on epidermal growth factor receptor39,43.  Epiregulin, the 
ligand for epidermal growth factor receptor, seems to be regulated by the fractalkine 
ligand, causing increased production of it, which causes cell proliferation43.  Fractalkine, 
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along with CCL2 and IL-8, are some of the few chemokines that are capable of inducing 
smooth muscle cell proliferation43.  Furthermore, epiregulin can be induced by 
angiogenic factors such as angiotensin II and thrombin, suggesting that cells involved in 
angiogenesis would be drawn towards epiregulin, as well as fractalkine43.  In the ovary, 
each of these factors may play a role in corpus luteum formation that involves the rapid 
revascularization of tissue. 
 Hormone fluctuations in the ovary may be playing a key role in regulating 
expression of many of these chemokines in ovarian cells, as chemokine expression seems 
to be cyclic1,19.  Luteinizing hormone may be one of the most influential hormones in 
altering chemokine expression in a timely fashion3.  CCL2 levels have been correlated to 
LH levels19.  Estrogen may also be involved in regulating time dependent expression of 
various cytokines and chemokines7.  For example, following lowered levels of estradiol, 
macrophage numbers increase for luteal regression1.  
 The reproductive system is complex; many cellular signals are required to recruit 
the cells that play pivotal roles in coordinating ovulation and corpus luteum formation. 
These signals, which include both hormones and chemokines, are precisely regulated to 
recruit white blood cells, such as monocytes and macrophages. These white blood cells 
then facilitate dynamic changes in ovarian tissue by promoting both inflammation and 
tissue repair, making follicular growth, ovulation, and corpus luteum formation possible. 
Gaining insight as to which cells and signals are involved in the reproductive system, as 
well as the complex interaction between them, will ultimately lead to a better 
understanding of fertility and fertility abnormalities.    
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Chapter 2 
Material & Methods 
Animal Handling and Hormone Injections  
Female cd1 and balb/c mice were obtained from Charles River (Roanoke, IL) at 
approximately three weeks of age and allowed to acclimate for one week.  Mice were 
then stimulated to ovulate via intraperitoneal injection using a super ovulation protocol 
(SP).  This included using 10 IU of pregnant mare serum gonadotropin (PMSG)(G4877; 
Sigma, St. Louis, MO) followed 48 hrs later by 10 IU of human chorionic gonadotropin 
(hCG)(CG10; Sigma).  Mice were euthanatized via carbon dioxide asphyxiation followed 
by cervical dislocation at the following time points post hormone injection: 48 hr post 
PMSG, 6 hr post hCG, 12 hr post hCG, 20 hr post hCG, and 24 hr post hCG.   All animal 
procedures were approved by Eastern Kentucky University’s Animal Care and Use 
Committee. 
Tissue Isolation and Flow Cytometry 
Spleens and ovaries were collected from all mice and processed accordingly.  Cell 
counts were performed by running 40μl of a 1:50 dilution of spleen and 1:10 dilution of 
ovarian cells on the Accuri C6 flow cytometer.  Single cell suspensions of approximately 
1x106 cells were then stained with antibodies specific to monocytes using a panel 
described in Table 1 and with antibodies specific to macrophages and other white blood 
cells using a panel described in Table 2.  Other panels were used to find M2-like 
macrophages (Table 3) and generalized white blood cells (Table 4).  Cells were washed 
once with PBA and then with PBS. Cells were resuspended in 50ul PBS and analyzed 
using an Accuri C6 flow cytometer (BD Biosciences, San Jose, CA).  Monocytes and 
macrophages were determined as a lineage− (all PE conjugated antibodies) and 
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CD11b+ population (Fig. 1). Ly-6c high monocytes were determined as the f4/
80−CD11c−Ia− and Ly − 6c+ population (Fig. 1).  Ly-6c low monocytes were 
determined as the f4/80−CD11c−Ia− and Ly − 6c− population (Fig. 1).   Macrophages 
were determined as the f4/80+CD11c+Ia+ and Ly − 6c− population (Fig. 1).  Data was 
compensated on the BD Accuri software. Data were analyzed and plotted using 
SigmaPlot version 11.0 (Systat Software, Inc., Chicago, IL).  On graphs, error bars 
represent one SEM around the average of data per group.  One-way ANOVA (Tukey 
test) was used to determine statistical significance among groups.  P < 0.05 was 
considered significant. 
Table 1. Antibodies and concentration used when creating cell staining mixture for finding 
macrophages, Ly6𝒄𝒉𝒊𝒈𝒉 and Ly6𝒄𝒍𝒐𝒘 monocytes.  
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
PBA - - - - 680 
FITC Ly-6c BD 
Biosciences 
553104 1:20 34 
APC-Cy7 CD11b BD 
Biosciences 
557657 1:20 34 
PE CD90.2 BD 
Biosciences 
553005 1:20 34 
PE B220 BD 
Biosciences 
553090 1:20 34 
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Table 1 (continued). 
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
PE CD49b BD 
Biosciences 
558759 1:20 34 
PE NK1.1 BD 
Biosciences 
557391 1:20 34 
PE LY-6g BD 
Biosciences 
561104 1:20 34 
APC f4/80 Biolegend 13116 1:20 34 
APC CD11c BD 
Biosciences 
561119 1:20 34 
APC Ia BD 
Biosciences 
562823 1:20 34 
 
Notes: All antibodies are mixed into PBA.  20ul of the mixture was added to each cell suspension 
and allowed to stain for a minimum of 20 minutes at 4°C.  Amounts listed account for staining 30 
samples.  Monocyte panel was designed based off of a previous study23.  The Accuri C6 was set 
to collect 50,000 events.  Laser settings were set to two red and two blue lasers.  FL1 lens was 
533/30, FL 2 lens was 585/40, FL 3 lens was 780/60, and FL4 lens was 675/25. 
Table 2. M1-like macrophage panel.  
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
PBA - - - - 680 
Alexa488 CD197 Biolegend 120110 1:20 34 
PE F4/80 Biolegend 123110 1:20 34 
 
 
30 
 
Table 2 (continued). 
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
APC-Cy7 CD3 BD 
Biosciences 
560590 1:20 34 
Alexa647 Ia BD 
Biosciences 
562367 1:20 34 
  
Notes: Antibodies and concentration used when creating cell staining mixture for M1 
macrophages.  All antibodies were mixed into PBA.  20ul of the mixture was added to each cell 
suspension to stain for 20 minutes at 4°C.  Amounts account for the staining of 30 samples.  The 
Accuri C6 was set to collect 50,000 events.  Laser settings were set to three red and one blue 
lasers.  FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens was 
675/25. 
 
Figure 5. Identification of monocyte and macrophage populations out of all leukocyte 
populations.  
The graph on the left identifies all monocytes and macrophages as lineage negative and cd11b 
positive cells.  The graph on the right specifically identifies ly-6c high and ly-6c low monocyte 
subsets and macrophages as positive for F4/80, cd11c, and IA within the first population 
identified (cd11b positive, lineage negative cells). 
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Additional Antibody Panels 
Table 3. M2-like macrophage panel.  
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
PBA - - - - 680 
FITC CD23 BD 
Biosciences 
553138 1:20 34 
PE F4/80 Biolegend 123110 1:20 34 
PE-Cy7 CD206 BD 
Biosciences 
141720 1:20 34 
APC CD11c BD 
Biosciences 
550261 1:20 34 
- FC Block BD 
Biosciences 
553142 - 10 
 
Notes: Antibodies and concentration used when creating cell staining mixture for M2-like 
macrophages.  All antibodies were mixed into PBA.  FC Block was added to cell suspensions for 
20 minutes before the antibody mixture was added.  20ul of the mixture was added to each cell 
suspension to stain for 20 minutes at 4°C.  Amounts account for the staining of 30 samples.  The 
Accuri C6 was set to collect 50,000 events.  Laser settings were set to three red and one blue 
lasers.  FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens was 
675/25. 
Table 4. General white blood cell panel.  
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
PBA - - - - 680 
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Table 4 (continued). 
Fluorochrome  Antibody Company Cat. 
No. 
 Dilution  Amount 
(ul) 
FITC CD3 Ancell 703-040 1:20 34 
PE F4/80 Biolegend 123110 1:20 34 
PercpCy5.5 Ly6g BD 
Biosciences 
560602 1:20 34 
APC CD11c BD 
Biosciences 
550261 1:20 34 
Notes: Antibodies and concentration used when creating cell staining mixture for general white 
blood cell populations.  All antibodies were mixed into PBA.  20ul of the mixture was added to 
each cell suspension to stain for 20 minutes at 4°C.  Amounts account for the staining of 30 
samples.  The Accuri C6 was set to collect 50,000 events.  Laser settings were set to three red and 
one blue lasers.  FL1 lens was 533/30, FL 2 lens was 585/40, FL 3 lens was 670LP, and FL4 lens 
was 675/25. 
Spleen Processing 
Following euthanasia at the specified times, spleens were harvested and processed 
by pushing them through 70µm filters and washed with PBS by centrifugation at 300xg 
for five minutes at 4ºC.  To reduce erythrocyte numbers, 3ml of 1x ACK was added for 
one minute, after which 5ml of PBS was added to reduce ACK activity.  Cells were then 
washed twice with PBS by centrifugation.  Cells were resuspended in 2ml of PBS and 
cell counts were performed on the single cell suspensions at a 1:50 dilution on the BD 
ACCURI.  Protocol was borrowed from and utilized as previously described48. 
Ovary Processing 
Following euthanasia of mice at the specified times, both ovaries were harvested 
and fatty tissue was carefully removed.  Ovaries were then minced into approximately 20 
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pieces and placed into 15ml tubes.  To remove remaining fatty tissue pieces, 10ml PBS 
was added to the tube, and all but 2ml of solution was removed from tube and disposed.  
Ovarian cells were allowed to settle 30 minutes before collagenase DNase solution (CDS) 
was added to break down collagen.  Tubes containing CDS and ovary cells were then 
incubated for 30 minutes at 37ºC.  Mixtures were then dissolved further by using a 
syringe with an 18G needle and filtered through a 70µm filter into a new 15ml tube.  
Cells were then centrifuged at 300xg for five minutes at 4ºC, supernatant was dumped, 
and cells were resuspended in 2ml HBSS.  Cell counts were performed on the single cell 
suspensions at a 1:10 dilution on the BD ACCURI.  Protocol was borrowed from and 
utilized as previously described7.  
Cumulous Oocyte Complex Counts 
Oviducts were collected from 20 hr post hCG mice in order to count cumulous 
oocyte complexes (COCs).  The oviducts were isolated and a small cut was made in the 
ampulla to allow the COCs to exit the oviduct.  The COCs were then counted under a 
microscope.  The average number found in one set (n=3) of hCG 20hr mice was 
determined to be the ovulation rate. 
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Figure 6. Oviduct from a mouse.  
The oviduct, after being isolated from the ovary.  The ampulla is distinct from the rest of the 
oviduct and it usually translucent.  Most cumulous-oocyte complexes reside in the ampulla.  
Photo courtesy of Dr. Phil Bridges. 
 Tissue embedding  
Ovaries and spleen were collected from mice and formalin fixed for three hours, 
then transferred to PBS.  Tissues were dehydrated through a series of hour-long graded 
ethanol baths.  They were then transferred into two baths of room temperature Histoclear 
II for an hour each and one bath of 55°C Histoclear II for 45 minutes for clearing.  The 
tissues were then placed into melted (55°C) paraffin to prepare for embedding.  Tissues 
were then embedded onto cassettes using disposable molds and a paraffin dispenser and 
were allowed to dry overnight.  Tissues were cut 7μm thick using a microtome.  Slides 
were allowed to dry overnight at 38°C.  
Immunohistochemistry 
Slides were then put in three 5 minute baths of Histoclear II to deparaffin, 
followed by a graded series of ethanol baths for 2 minutes each to rehydrate the tissue.  
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Tissues underwent antigen retrieval (specific to each primary antibody), which included 
warming antigen Retrievagen A (BD Biosciences, Cat. No. 550524) or B (BD 
Biosciences, Cat. No. 550527) in a microwave for 5 minutes to approximately 192°F and 
then heating the slides in the solution for up to 20 minutes (Table 5).  Slides were allowed 
to cool for about 5 minutes.  Tissue was circled with a pap pen. Bloxall (Vector, Cat. No. 
SP-6000) was placed on all tissues for ten minutes to block endogenous peroxidase 
binding.  Slides were rinsed with Tris Buffered Saline (TBS) with Tween and then 10% 
Normal Goat Serum Block (Vector, Cat. No. S-1000) was applied to all tissue for 5 
minutes.  Normal serum was dumped off and primary antibody was applied (Table 5).  
Primary antibody was rinsed off using TBS with Tween and then Goat anti-Rabbit 
(Vector, Cat. No. BA-1000) at a 1:500 dilution was applied for 15 minutes.  Slides were 
again rinsed with TBS with Tween and then Elite ABC Reagent (Vector, Cat. No. PK-
7100) was added for 15 minutes.  This solution was rinsed off using TBS with Tween and 
then Cardassian DAB, (Biocare Medical, Cat. No. DBC859H), a chromagen substrate, 
was added onto the tissue for 5 minutes or until color appeared.  The chromagen substrate 
was thoroughly rinsed off with TBS with Tween.  Slides were then counterstained for 15 
seconds with Hemotoxylin.  Slides were then rinsed for two minutes with 95% ethanol, 
two washes of 100% ethanol for two minutes each, and two washed of Histoclear II for 
two minutes each.  Slides were dried and a coverslip was placed over the tissue using 
Permount.  Slides were allowed to dry overnight and examined under microscope for 
positive colored cells.  Protocol borrowed from previous studies49. 
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Table 5. Primary antibodies used in immunohistochemistry along with antigen retrieval 
specifics and incubation times.  
Primary 
Antibody  
Company Cat. No. Retrievagen  Dilution Incubation 
B220/ 
CD45R 
BD 
Biosciences 
557390  B, 5 min 1:100 4°C, 
overnight 
CD30 BD 
Biosciences 
553824 A, 10 min 1:100 4°C, 
overnight 
Anti-PE-
CAM1 
R & D 
Systems 
af3628 A, 10 min 1:100 4°C, 
overnight 
Anti-
neutrophil 
elastase 
antibody 
Abcam ab68672 A, 20 min 1:2000 Room 
temperature, 
2 hours 
CD45 Abcam ab10558 A, 10 min 1:100 4°C, 
overnight 
 
Notes: Primary antibody dilutions are also included.  B220 was used to identify B cells, CD30 
was used to identify activated B and T cells, anti-PE-CAM was used to identify blood vessels and 
endothelial cells, CD45 was used to identify white blood cells in general, and anti-elastase was 
used to identify functional neutrophils. 
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Chapter 3 
Results 
Leukocyte infiltration of ovary 
 Leukocyte infiltration into the ovary was counted by collecting total events by 
flow cytometry.  Cells were only counted if they were larger than red blood cells.  A 
significant increase was found in the group hCG 6hr compared to the control group, 
showing the increase in leukocyte infiltration prior to ovulation. 
 
Figure 7. Total cell count in ovaries during ovulation.  
The number of leukocytes in the ovary increases during ovulation as compared to immature 
control mice.  The group hCG 6hr was significantly increased compared to the control.  Different 
letters show significant difference.  Results represent mean ± SEM of n=3 mice and are 
representative of 3 experiments (p<0.05, ANOVA + Tukey).  
Ly6𝒄𝒉𝒊𝒈𝒉 Monocytes 
 Ly6𝑐ℎ𝑖𝑔ℎ monocytes that were stained and counted by flow cytometry showed a 
significant increase in percentages and absolute numbers for group hCG 6hr compared to 
all other groups.  For absolute numbers, hCG 12hr was also significantly increased 
compared to the control group.  
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Figure 8. Gating strategy for ly6c high and low monocytes.  
An unstained sample of ovarian cells was used to create gates yielding positive populations 
that were 1% or less which were then applied to all samples.  Cell other than leukocytes were 
gated out first based off of small size.  CD11b+ and lineage negative cells were then selected and 
narrowed into either ly6c high or low monocytes.  These cells were further defined by lack of 
expression of IA, F480, and CD11c.  Ly6𝒄𝒉𝒊𝒈𝒉 monocytes fell into the lower right quadrant while 
Ly6𝒄𝒍𝒐𝒘 monocytes fell into the lower left quadrant.
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Figure 9. Percentage (left) and absolute number (right) of ly6𝒄𝒉𝒊𝒈𝒉 monocytes in the ovary 
at different time points during ovulation.  
Demonstrates the influx of ly6𝒄𝒉𝒊𝒈𝒉 monocytes during ovulation, specifically before ovulation 
occurs at hCG 6hr.  Group hCG 6hr is significantly increased compared to all other groups in 
both percentage and absolute numbers.  Group hCG 12hr is also increased compared to control 
for absolute numbers.  Different letters show significant difference.  Results represent mean ± 
SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey). 
Ly6𝒄𝒍𝒐𝒘 Monocytes 
The gating strategy for ly6𝑐𝑙𝑜𝑤 monocytes was the same as depicted in figure 8.  
Ly6𝑐𝑙𝑜𝑤 monocytes showed a delayed increase in absolute numbers, appearing after 
ovulation at the time point hCG 20hr.  A significant increase was found in group hCG 
20hr compared to groups control, PMSG 48hr, and hCG 12hr.  
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Figure 10. Percentage (left) and absolute number (right) of ly6𝒄𝒍𝒐𝒘 monocytes in the ovary 
during ovulation. 
Demonstrate the appearance of ly6𝑐𝑙𝑜𝑤 monocytes post ovulation.  Group hCG 20hr is 
significantly increased compared to groups control, PMSG 48hr, and hCG 12hr in absolute 
numbers.  Different letters show significant difference.  Results represent mean ± SEM of n=3 
mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey).  
CD11c+ Dendritic Cells 
 No significant difference was found for CD11c positive cells, nor was any trend 
noticed.  CD11c positive cells did not seem to be entering the ovary.  
 
 
41 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Gating strategy for CD11c positive cells. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  A histogram was then created showing all CD11c positive cells. 
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Figure 12. Percentage (left) and absolute number (right) of CD11c+ staining cells in ovary 
during ovulation.  
Results do not show much of a trend, indicating static behavior for dendritic cells.  No significant 
difference between groups was found.  Results represent mean ± SEM of n=3 mice and are 
representative of 3 experiments (p<0.05, ANOVA + Tukey). 
 
 
42 
 
CD206+ M2-like Macrophages 
No significant difference was found for CD206 positive cells, nor was any trend 
noticed.  CD206 positive cells did not seem to be entering the ovary.  
 
 
 
 
Figure 13. Gating strategy for CD206 positive cells. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  Next F480+ cells were selected, and further defined on a 
histogram as CD206 positive cells. 
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Figure 14. Percentage (left) and absolute number (right) of CD206+ cells in ovary during 
ovulation.  
Results do not indicate any real trend.  An increase in CD206 cells may be occurring at hCG 20hr 
as absolute numbers doubled.  No significant difference was found between groups.  Results 
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + 
Tukey). 
CD197+/IA+ M1-like Macrophages 
No significant difference was found for CD197/Ia positive cells, nor was any trend 
noticed.  CD197/Ia positive cells did not seem to be entering the ovary.  
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Figure 15. Gating strategy for M1-like macrophages. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  Next F480+ cells were selected, and further defined as being 
double positive for Ia and CD197.  These cells fell into the upper right quadrant. 
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Figure 16. Percentage (left) and absolute number (right) of CD197+/IA+ M1-like 
Macrophages in the ovary during ovulation.  
Results show an increase in M1-like macrophage absolute numbers during ovulation compared to 
the control group.  No significant difference was found between groups.  Results represent mean 
± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + Tukey). 
Ly6g+ Neutrophils 
No significant difference was found for Ly6g positive cells, although an 
increasing trend was noticed in neutrophil numbers.  Ly6g positive cells are likely 
entering the ovary throughout ovulation.  
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Figure 17. Gating strategy for ly6g+ cells. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  A histogram was then created showing all ly6g positive cells. 
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Figure 18. Percentage (left) and absolute number (right) of Ly6g+ neutrophils in the ovary 
during ovulation.  
Results indicate a trend showing an increase in neutrophil absolute numbers during ovulation 
compared to the control group.  No significant difference was found between groups.  Results 
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + 
Tukey). 
CD3+ T Cells 
No significant difference was found for CD3 positive cells, nor was any trend 
noticed.  CD3 positive cells did not seem to be entering the ovary.  
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Figure 19. Gating strategy for CD3+ cells. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  A histogram was then created showing CD3 positive cells. 
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Figure 20. Percentage (left) and absolute number (right) of CD3+ T cells in the ovary 
during ovulation.  
Results do not indicate any real trend.  There was a significant difference between the control 
group compared to all four other groups in percentage graph.  Different letters show significant 
difference.  Results represent mean ± SEM of n=3 mice and are representative of 3 experiments 
(p<0.05, ANOVA + Tukey).  
F4/80+ Macrophages 
No significant difference was found for F4/80 positive cells, although an 
increasing trend was noticed in macrophage numbers.  F4/80 positive cells are likely 
appearing in the ovary during ovulation.  
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Figure 21. Gating strategy for F480+ cells. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  A histogram was then created displaying all F480 positive cells. 
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Figure 22. Percentage (left) and absolute number (right) of F480+ T cells in the ovary 
during ovulation.  
Results suggest an increase in absolute numbers of macrophages during ovulation.  No significant 
difference was found between groups.  Results represent mean ± SEM of n=3 mice and are 
representative of 3 experiments (p<0.05, ANOVA + Tukey). 
 
Recruitment of Leukocytes from Spleen 
In percentage, a significant decrease, particularly for the 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocyte, in 
the spleen was demonstrated for groups hCG 6hr, hCG 12hr, and hCG 24hr compared to 
the control.  There was also a significant decrease in groups hCG 6hr compared to PMSG 
48hr. For absolute number, a significant decrease in the spleen was demonstrated in 
groups hCG 6hr and hCG 24hr compared to the control group.  The spleen appears to be 
losing 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocytes during times that coincide with ovulation.  
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Figure 23. Gating strategy for splenic leukocytes. 
An unstained sample of ovarian cells was used to create gates yielding positive populations that 
were 1% or less which were then applied to all samples.  Cell other than leukocytes were gated 
out first based off of small size.  CD11b+ and lineage negative cells were then selected and 
narrowed into either ly6c high or low monocytes.  These cells were further defined by lack of 
expression of IA, F480, and CD11c.  Ly6𝑐ℎ𝑖𝑔ℎ monocytes fell into the lower right quadrant while 
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Ly6𝑐𝑙𝑜𝑤 monocytes fell into the lower left quadrant.
 
Figure 24. Percentage (left) and absolute number (right) of ly6𝒄𝒉𝒊𝒈𝒉 monocytes in the spleen 
at different time points during ovulation.  
Demonstrates a trend that leukocyte numbers, particularly for ly6𝒄𝒉𝒊𝒈𝒉 monocytes, fall during 
ovulation.  Groups hCG 6hr, hCG 12hr, and hCG 24hr are significantly decreased compared to 
the control group for percentage.  Group hCG 6hr is also significantly lower compared to group 
PMSG 48hr for percentage.  For absolute numbers, groups hCG 6hr and hCG 24hr are 
significantly lower than group PMSG 48hr.  Different letters show significant difference.  Results 
represent mean ± SEM of n=3 mice and are representative of 3 experiments (p<0.05, ANOVA + 
Tukey). 
Cumulous Oocyte Complex Counts 
 Oviducts were first isolated from the ovaries in mice taken at hCG hour 20.  The 
ampulla of the oviduct was then cut, expelling most COCs from the oviduct in a clump.  
Fine tweezers were then used to tease remaining COCs from the oviduct.  The oocytes in 
these complexes were then counted under microscope and then averaged to determine 
ovulation rate.  Ovulation rates ranged from 14 to 29.  Reduced rates in trials 2, 4, and 5 
had one mouse that did not have distinct ampullas full of COCs, which lowered the 
overall ovulation rate. 
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Figure 25. Ovulation rate determined by counting cumulous oocyte complexes in hCG 20hr 
mice.  
Oviducts were isolated in hCG 20hr mice and the ampulla was cut to release cumulous oocyte 
complexes which were then counted.  Numbers for both ovaries in mice were averaged to 
determine ovulation rate.  Average ovulation rate ranges between approximately 14 and 29.  
Results represent mean of n=3 mice for seven experiments. 
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Figure 26. Cumulous oocyte complexes under the microscope.  
Five distinct oocytes along with numerous small cumulous cells can be seen.  Each visible oocyte 
was counted and averaged per group to determine ovulation rates. 
Immunohistochemistry 
Ovary, oviduct, and spleen tissue were all stained with hematoxylin and eosin for basic cell 
structures.  A rat anti-mouse B220 primary antibody was utilized to detect B cells in all three 
tissues.  Cells stained positive for B220 in the spleen, but not in the ovary or oviduct, suggesting 
B cells are not present or necessary in ovulation.   
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Chapter 4 
Discussion 
Leukocyte infiltration into the ovaries is a key factor in the physiological process 
of ovulation, that is now well recognized as an inflammatory response.  We identified 
several leukocyte populations infiltrating the ovarian tissue, including monocytes, 
macrophages, and granulocytes including neutrophils and eosinophils.  Previous studies 
have identified a variety of leukocyte products found in the ovaries, including proteases, 
cytokines, and chemokines, that promote leukocyte recruitment and inflammation.  The 
presence of leukocytes and their products indicates they are necessary for facilitating 
ovarian processes, such as steroidogenesis, breakdown of the basement membrane of the 
follicular wall for ovulation, angiogenesis and vascularization of the corpus luteum, and 
degradation of a collapsing corpus luteum. 
Referring to Figure 7, which shows the total number of cells in the ovary, it seems 
clear that prior to ovulation, the cell totals begin to increase, and the ovary seems to 
double in size.  This was evident by observing ovaries taken from mice at each time point 
during ovulation, as control mice had very small, pale ovaries, and mice at any stage 
during ovulation had much bigger, pink ovaries.  Upon close examination, many of these 
ovaries also had multiple follicles visible.  This indicates that leukocytes must serve some 
function in the process of ovulation, although we believe they likely serve multiple 
purposes.  Many cells that come into the ovary prior to ovulation likely serve in an 
inflammatory role, while the cells coming in after ovulation probably serve reparative 
functions. 
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The ly6𝑐ℎ𝑖𝑔ℎ  monocyte is one of the first cells we have identified that are 
recruited the ovary prior to ovulation.  These monocytes seem to peak in number at hCG 
hour 6, which is before ovulation occurs in mice.  This means they are most likely 
involved in inflammatory processes, as they can differentiate into M1-like macrophages 
and help to break down the wall of follicles in the ovary so that the oocyte can be 
released.  The numbers of these monocytes quickly decrease, as their role finishes when 
ovulation occurs. This may indicate that they are either leaving the ovary or 
differentiating into other cell types, including ly6𝑐𝑙𝑜𝑤 monocytes, which can then 
differentiate into M2-like macrophages for tissue repair.  The large number of ly6𝑐ℎ𝑖𝑔ℎ 
monocytes may simply arrive in the ovary before ovulation occurs simply to serve as a 
source of both types of macrophages, since they are versatile and can become either one 
based on cellular cues in the tissue environment they infiltrate.  The population of 
ly6𝑐ℎ𝑖𝑔ℎ cells is transient, as these are short lived cells that down-regulate ly6c 
expression quickly and differentiate into macrophages27,31. 
Two cell types that do not seem to be playing a role in ovulation are the dendritic 
cells and T cells.  Cells that stained positive for CD11c are generally accepted to be 
dendritic cells, and cells that stain positive for CD3 are T cells.  From our results, 
absolute numbers of dendritic cells and T cells in the ovaries do not seem to be increasing 
or decreasing.  This would suggest that they likely are not playing a major role in 
ovulation.  It is logical that T cells would not play a role because they are involved in 
acquired immunity, and ovulation is a naturally occurring process with no foreign 
particles involved.  However, other studies have indicated the presence of T cells in the 
 
 
58 
 
ovaries during corpus luteum development, so more studies should be done to determine 
their role. 
The M2-like macrophages were designated as CD206+ cells.  These cells did not 
really exhibit any significant pattern or trend in our results.  If anything, it looks as if 
there may have been an increase in M2-like macrophages after the resolution of ovulation 
at hCG 20hr.  This would make sense because these macrophages tend to help repair 
tissue and clean up cellular debris left behind from other cells.  These assays should be 
repeated with a more specific antibody, however, as the antibody used for CD206 did not 
demonstrate sufficient effectiveness.  This may have been due to low CD206 expression 
or some other reason, but it made it difficult to differentiate M2-like macrophages from 
other cell types.  Therefore it is advisable to repeat the flow cytometry assays to better 
identify this population of cells.  
M1-like macrophages were designated as double positive for CD197 and IA.  The 
results show an increase in these cells during ovulation.  As these are inflammatory in 
nature, this seems probable.  However, as seen with the CD206 antibody, the CD197 
antibody did not produce good results, making it hard to differentiate M1-like 
macrophages from other populations.  This may also have been because of low CD197 
expression. This population should also be better differentiated, perhaps by using a 
different antibody or by searching for a different unique M1 macrophage antigen.  
Any cells that stained positive for ly6g were designated as neutrophils.  
According to our results, it appears that neutrophils doubled in number throughout 
ovulation.  Neutrophils are part of the innate immune system and are highly 
inflammatory, so it would make sense that they would be involved in ovulation.  They 
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could potentially be helping follicles rupture by releasing inflammatory cytokines to 
degrade the follicular wall until the oocyte is released.  Others suggest that neutrophils 
may be recruited to the ovary by other leukocytes, possibly by monocytes.  
We also used a general marker for macrophages, called F4/80, to identify them in 
the ovary.  Our results, although not significant, show that after administering hCG, 
F4/80 positive cells double in absolute number in the ovary.  These would include both 
M1-like macrophages, for promoting inflammation and follicular rupture, and M2-like 
macrophages, for repairing tissue and bringing ovarian tissue back to the start of the 
ovulatory process.  The numbers for generic macrophages remain high throughout 
ovulation because both M1 and M2 populations play important roles and are active at 
different points throughout ovulation.   
The spleen is a known lymphoid organ, and in our case, may act as a source of 
cell donation for the ovaries.  Our results show immature control mice having many more 
leukocytes in their spleen than mice taken during ovulation.  The spleen, just as it donates 
white blood cells to a site of injury, may also be donating some leukocytes to the ovaries 
and other reproductive tissues to help the process of ovulation occur.  This is probably 
due to the fact that ovulation requires inflammatory factors to occur and reparative 
factors to help restore tissue after ovulation occurs.  
Counting cumulous oocyte complexes (COCs) proved to be a challenging task, as 
each pair of ampullas had to be separated from the ovaries in a delicate manner so as not 
to tear the ampullas and lose any COCs.  This process was made significantly easier by 
using fine scissors and tweezers, which could make precise cuts without tearing the 
ovaries or ampullas.  The complexes are also very mucous-like and tend to stick to each 
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other, making it difficult to count.  However, there was a distinct bulge in every ampulla 
that actually held all the COCs, making them easier to locate.  If the distinct bulge was 
not present on the ampulla, it usually meant no or very few COCs would be found.  
Overall, the results for ovulation rates ranged between 14 and 29 COCs.  Lower ovulation 
rates usually had one mouse that did not have distinctive ampulla bulges, causing the 
average to be reduced.  These ovulation rates are a good basis for future experiments 
investigating the effect of specific compounds on ovulation.  For instance, we would 
expect lowered ovulation rates from mice that were given a drug that would stop the 
activity of luteinizing hormone.  
When I began this project, I used one panel of antibodies for flow cytometry, 
which was designed for isolating ly6𝑐ℎ𝑖𝑔ℎ  and ly6𝑐𝑙𝑜𝑤 monocytes, and 
CD11c+/IA+/F480+ cells, which would have included macrophages and dendritic cells. 
After learning the basics of flow cytometry, I designed new panels that were designed to 
isolate macrophages, and later narrowed it down to a panel for M1-like macrophages and 
a panel for M2-like macrophages. However, there was one antibody from each of these 
panels that was very inefficient, and therefore we could never obtain conclusive results 
on these macrophages. The M1 panel antibody that did not work well was CD197, and 
the M2 panel antibody was CD206. It is likely that CD197 is not significantly expressed, 
which made it difficult to isolate from other cell types. The antibody for CD206 is for a 
receptor that is found inside the cell, so we utilized intracellular staining. Again, we were 
unable to effectively identify M2-like cells from other cell types. Other flow markers for 
M2-like macrophages that may potentially work better for future panels include CD64 
and MerTK34. 
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Our immunohistochemistry experiments were more recent attempts to identify the 
cells, and were not fully completed.  We were only able to successfully stain a few 
leukocyte markers.  We used formalin fixed tissues, which creates problems by masking 
our antigens, making them not accessible to antibodies. Another possible problem may 
have been due to our use of a microwave to heat the tissue before we stained, which may 
have denatured our antigens beyond antibody recognition. 
Future Aims 
 One of the first priorties is to complete the immunohistochemistry assays.  We 
must first identify useful antibodies to stain specific white blood cells using the spleen 
tissue as a control, and then progress to ovarian tissue to identify where in the ovary these 
cells were going.  This will help to elucidate the location of the cells infiltrating the 
ovary, as flow cytometry only indicates how many were entering.  Without knowing 
where these cell types are located in the ovary, it is harder to say with certainty what their 
function is.  After we are able to identify where these cells are going, it would also be of 
interest to stain for specific cytokines and chemokines, particularly those that are 
inflammatory in ovarian tissue, taken before and during ovulation, or cytokines that are 
able to mend tissue in ovary sections taken after ovulation is over.  This would further 
clarify the function of many of these cells. 
 It may also be informative to use cell cultures of ovarian tissue to test for cytokine 
and chemokine production.  After getting an idea of baseline production, the addition of 
specific leukocyte populations should cause increased production of particular cytokines 
and chemokines.  It may be interesting to see how 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocytes affect cytokine 
production.  As an alternative, cell growth could be altered in response to particular 
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cytokines and chemokines, supporting the idea that leukocytes are promoting tissue 
remodeling after ovulation.  Cell culture could provide new insight into chemokine 
activities during ovulation. 
 Another project would be to search for a better marker to use for the M1 and M2-
like panels.  RT-PCR could also be used to identify M1- and M2-like macrophages in the 
ovaries, since there are not very efficient antibody markers available.  RT-PCR would be 
able to quantify levels of mRNA using macrophage markers that are not as easily 
detected via flow cytometry.  
 Together with narrowing down macrophage involvement, we could perform more 
experiments looking for neutrophils and determining their role in ovulation.  Designing a 
flow panel to identify them is easily manageable and since they are an innate white blood 
cell, they appear to be a good candidate for playing a role in ovulation as well.  Ovulation 
is naturally occurring so it would make sense that these innate cells, which are 
inflammatory cells, might be involved at some level.  Furthermore, many studies have 
also been able to determine that neutrophils do appear in the ovary, particularly around 
the basement membrane of mature follicles.  As monocytes have been shown to be able 
to regulate neutrophil activity in response to commensals and their products, it would be 
of interest to discern whether they also regulate neutrophils in ovarian tissue37. 
 Further studies should be conducted on the effect of estrogen on ovulation.  
Estrogen is generally regarded to be an anti-inflammatory hormone and is highly 
involved in the process of ovulation.  Estrogen levels remain elevated prior to ovulation, 
and once they drop, ovulation is able to occur.  An influx of leukocytes is also seen after 
estrogen levels drop, coinciding with ovulation.  This suggests that estrogen acts as one 
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of the key signals for leukocyte recruitment.  Preliminary experiments administering 
estradiol to mice were performed following super ovulation, but more experiments need 
to be done to determine the precise effect it had on leukocyte infiltration.  Along with this 
aspect, it would be ideal to see the effect of estradiol inhibitors on ovulation.  For 
instance, estrogen inhibitors should block the anti-inflammatory effect of estrogen, 
potentially allowing leukocytes to enter prematurely in the ovary.  This would no doubt 
have an effect on ovulation success, possibly causing premature follicle rupture.    
 It would also be a good idea to see the effect that administering leukocyte 
inhibitors has on ovulation.  If leukocytes are truly are involved in helping ovulation 
occur, then blocking their migration to the ovary should effectively reduce the ability to 
ovulate.  This should be easy to discern by looking to see whether ovarian cell counts 
increase after ovulation, and by checking ovulation rate by counting COCs.  If cell counts 
remain low and similar to control mice, and ovulation rates are low, it would effectively 
support the role leukocytes have in ovulation.  Inhibitors for monocytes and neutrophils 
would be a great starting point for this idea, specifically looking at inhibitors for CCR2, 
which is a major chemokine found on monocytes.   INCB3344 is a drug that has been 
shown to be an effective and efficient antagonist for blocking monocyte recruitment.  
This drug can be administered orally to mice and binds to CCR2 on monocytes, 
effectively inhibiting monocyte extravasation46,47.  A drug candidate for blocking 
fractalkine and ly6𝑐𝑙𝑜𝑤 monocytes is AZ1220118239,43.  This particular drug is specific to 
the receptor C𝑋3𝐶𝑅1 and can inhibit the pro-survival effects of fractalkine and also block 
mRNA production of epiregulin43.  An option for inhibiting neutrophil infiltration is the 
drug DF 2156A, which is a potent, non-competitive, allosteric inhibitor for both the 
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CXCR1 and CXCR2 receptors45.  It is important to note that by blocking one type of 
leukocyte, the lack of that particular cell’s influence and products could indirectly cause 
decreased recruitment of other white blood cells. 
Due to chemokine redundancy, leukocytes may still be recruited to tissue using 
other routes, so an alternative to merely blocking chemokines and their receptors would 
be to use knockout mice that do not express the chemokine receptors at all.  To test how 
important monocytes in particular are to ovulation, running the same experiments on 
CCR2 knockout mice would be advantageous.  These mice should have normal numbers 
of white blood cells, but monocytes and macrophages would not express CCR2, making 
them much less likely to be recruited to tissue36.  Monocyte infiltration into the ovary 
should be reduced, and in theory would result in reduced ovulation rate. 
 In summary, we were able to positively identify the presence of numerous 
leukocytes in the ovaries, including monocytes, macrophages, and neutrophils.  We were 
able to narrow down specifically 𝑙𝑦6𝑐ℎ𝑖𝑔ℎ monocyte infiltration as occurring before 
ovulation, supporting the notion that these inflammatory leukocytes promote degradation 
of the basement membrane of the follicle.  We were also able to correlate influx of 
leukocytes in the ovary to a decreased number in the spleen, suggesting the spleen as a 
source for additional leukocytes.  The presence of these white blood cells in the ovaries 
supports the need for leukocyte involvement in successful ovulation.  Reproductive 
immunology, although a fairly recent field of study, proves to be a promising approach to 
determining means to help increase fertility in women who have a variety of either 
reproductive or immune diseases.  The results substantiate this idea and suggest that 
novel therapies could be developed based on the immune response.    
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Immunohistochemistry Results 
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Figure 27. Tissue from spleen and ovary stained with B220.  
Splenic tissue (left) stained positive for the antibody B220, indicating the presence of B cells. 
Ovarian tissue (right) did not stain positive for the antibody B220, indicating no B cells were 
present. 
 
 
 
 
 
 
 
 
  
Figure 28. Additional H&E stained tissue.  
Ovarian tissue (left) and oviduct tissue (right) stained with hematoxylin and eosin. The arrow 
points out a follicle in the ovarian tissue. 
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Appendix B: 
Preliminary Estrogen Results 
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Figure 29. Leukocyte infiltration into ovaries.  
Estrogen is causing an increase in leukocyte infiltration compared to the same groups that did 
not receive estrogen. For percentage, group hCG 20 plus estrogen was significantly different 
from groups control, PMSG 48hr, and hCG 12hr. The group hCG 20hr plus estrogen was also 
significantly different from the control group for absolute numbers. Different letters show 
significant difference.  Results represent mean ± SEM of n=3 mice and are representative of 3 
experiments (p<0.05, ANOVA + Tukey). 
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